newsfilter
← Latest News
PR Newswire·

Neurocrine Biosciences Reports First-Quarter 2026 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2026. "Neurocrine's strong...